In The News,
Minimal Residual Disease Test
Provided a roadmap for a molecular diagnostics company developing a new technology to detect minimal residual disease to secure Current Procedural Terminology (CPT) coding and positive Medicare coverage and reimbursement in the US.
Interested in hearing more from us?
Receive customized email alerts from the ADVI team